A new study on the effects of the COVID-19 infection on obese people has found that it has high chances of fatality among them, and vaccines, when they are eventually introduced to the public, may also not be as effective on obese people.
It has already been established that older people and those who are immunocompromised are at a higher risk of contracting the severe symptoms of COVID-19 if they contract the new coronavirus infection. This includes people with underlying conditions such as diabetes, obesity, heart disease, respiratory diseases such as asthma and COPD, cancer and high blood pressure.
The latest study, conducted by researchers from the University of North Carolina, the World Bank and the Saudi Health Council, found that the chances of death among obese patients with COVID-19 was 48% higher than non-obese patients. Additionally, they said, any new vaccine that would be rolled out would be less effective among the obese population. The findings of the study were published in the journal Obesity Reviews.
So far, more than 24 million people have been affected by this viral infection that has also claimed more than 826,000 lives globally, putting several more lives at risk due to the burden of various other illnesses and complications. According to a 2016 report by the World Health Organization (WHO), more than 1.9 billion adults are overweight and 650 million out of them are obese.